Abstract
Novel pH-sensitive hydrogels were developed as suitable candidates for carriers in bioMEMS devices as well as for oral delivery of therapeutic peptides and proteins due to their ability to respond to environmental pH change. Macromonomers containing various PEG molecular weights were synthesized and used to prepare P(MAA-g-EG) hydrogels were by photopolymerization. P(MAA-g-EG) hydrogels showed a drastic change of the equilibrium swelling ratio between pH 2.2 and 7.0. At pH 7.0, hydrogels with PEGMA2000 exhibited higher swelling ratio than hydrogels with PEGMA1000. For both hydrogels with PEGMA1000 and PEGMA2000, the swelling mechanism became more relaxation-controled as the environmental pH changed from 2.2 to 7.0 due to the ionization of the functional groups in polymer networks at high pH. In vitro release studies of insulin were conducted. P(MAA-g-EG) hydrogels exhibited drastic increase of insulin release as the pH of the medium was changed from acidic to basic. Insulin release from P(MAA-g-EG) hydrogels with PEGMA2000 was slower than from hydrogels with PEGMA1000 at both low and high pH. These results were used to design and improve protein release behavior from these carriers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
P.-Å. Albertsson, A. Cajarville, D.E. Brooks, and F. Tjerneld, Biochim. Biophys. Acta 926, 87-93 (1987).
J.F. Arrieta-Molero, K. Aleck, M.K. Shina, C.M. Brownschneidle, L.J. Shapiro, and M.A. Sperling, Horm. Res. 16, 249-256 (1982).
C.L. Bell and N.A. Peppas, Biomaterials 17, 1203-1218 (1996).
A. Bernkop-Schnürch, J. Control. Release 52, 1-16 (1998).
P. Couvreur and F. Puisieux, Adv. Drug Deliver. Rev. 10, 141-162 (1993).
N.V. Efremova, Y. Huang, N.A. Peppas, and D.E. Leckband, Langmuir 18, 836-845 (2002).
D.J. Enscore, H.B. Hopfenberg, and V.T. Stannett, Polymer 18, 793-800 (1977).
Y. Gnanou and P. Rempp, Makromol. Chem 188, 2111-2119 (1987).
J.M. Harris, Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications (Plenum Press, New York, 1992).
Y. Huang, W. Leobandung, A. Foss, and N.A. Peppas, J. Control. Release 65, 63-71 (2000).
B. Kim, K. La Flamme, and N.A. Peppas, J. Appl. Polym. Sci. 89, 1606-1613 (2003).
V.H.L. Lee and A. Yamamoto, Adv. Drug Deliver. Rev. 4, 171-207 (1990).
A.M. Lowman, M. Morishita, M. Kajita, T. Nagai, and N.A. Peppas, J. Pharm. Sci. 88, 933-937 (1999).
A.M. Lowman and N.A. Peppas, Polymer 41, 73-80 (2000).
F. Madsen and N.A. Peppas, Biomaterials 20, 1701-1708 (1999).
K. Moriyama, T. Ooya, and N. Yui, J. Control. Release 59, 77-86 (1999).
K. Moriyama and N. Yui, J. Control. Release 42, 237-248 (1996).
H.M. Patel, R.W. Stevenson, J.A. Parsons, and B.E. Ryman, Biochim. Biophys. Acta 716, 188-193 (1982).
N.A. Peppas and J.J. Sahlin, J. Biomat. Sci., Polym. Ed. 8, 421-436 (1997).
P.L. Ritger and N.A. Peppas, J. Control. Release 5, 37-42 (1987).
D.N. Robinson and N.A. Peppas, Macromolecules 35, 3668-3674 (2002).
A. Rubinstein, B. Tirosh, M. Baluom, T. Nassar, A. David, R. Radai, I. Gliko-Kabir, and M. Friedman, J. Control. Release 46, 59-73 (1997).
M. Shichiri, Y. Shimizu, Y. Yoshida, R. Kawamori, M. Fukychi, Y. Shigeta, and H. Abe, Diabeologia 10, 317-321 (1974).
M. Torres-Lugo, M. García, R. Record, and N.A. Peppas, J. Control. Release 80, 197-205 (2002).
M. Torres-Lugo and N.A. Peppas, Macromolecules 32, 6646-6651 (1999).
M. Torres-Lugo and N.A. Peppas, Biomaterials 21, 1191-1196 (2000).
J.F. Woodley, Crit. Rev. Ther. Drug 11, 61-95 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, B., Peppas, N.A. Poly(ethylene glycol)-containing Hydrogels for Oral Protein Delivery Applications. Biomedical Microdevices 5, 333–341 (2003). https://doi.org/10.1023/A:1027313931273
Issue Date:
DOI: https://doi.org/10.1023/A:1027313931273